港股異動丨Qwen3發佈促阿里概念股走強,阿里健康升8%,耀才證券金融升14%
阿里發佈Qwen3,港股市場阿里概念股今日集體走強。其中,新成員耀才證券金融在昨日收升81%後,今日盤中再度升超14%再創歷史新高;阿里健康升8%。消息面上,29日凌晨,阿里巴巴宣佈推出新一代通義千問模型Qwen3(千問3)並進行開源。阿里雲方面表示,千問3是國內首個“混合推理模型”,將“快思考”與“慢思考”集成進同一個模型,參數量僅為DeepSeek-R1的1/3,成本大幅下降,並在ChatBot Arena等榜單中性能全面超越R1、OpenAI-o1等全球頂尖模型,登頂全球最強開源模型。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.